A Study Comparing Two Different PROCRIT Doses to a Dose of ARANESP in Anemic Cancer Patients Receiving Chemotherapy
Public ClinicalTrials.gov record NCT00386152. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open-Label, Comparative Study of Epoetin Alfa (PROCRIT) 80,000 Units or 120,000 Units Q3W (Every 3 Weeks) Versus Darbepoetin Alfa (ARANESP) 500 Mcg Q3W in Anemic Cancer Subjects Receiving Chemotherapy
Study identification
- NCT ID
- NCT00386152
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Industry
- Enrollment
- 235 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2006
- Primary completion
- Feb 29, 2008
- Completion
- Apr 30, 2008
- Last update posted
- Jul 18, 2013
2006 – 2008
United States locations
- U.S. sites
- 76
- U.S. states
- 29
- U.S. cities
- 76
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Glendale | Arizona | — | — |
| Not listed | Jonesboro | Arkansas | — | — |
| Not listed | Little Rock | Arkansas | — | — |
| Not listed | Anaheim | California | — | — |
| Not listed | Bakersfield | California | — | — |
| Not listed | Corona | California | — | — |
| Not listed | Fountain Valley | California | — | — |
| Not listed | Fullerton | California | — | — |
| Not listed | Greenbrae | California | — | — |
| Not listed | Irvine | California | — | — |
| Not listed | La Jolla | California | — | — |
| Not listed | La Verne | California | — | — |
| Not listed | Lancaster | California | — | — |
| Not listed | Long Beach | California | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | Northridge | California | — | — |
| Not listed | Orange | California | — | — |
| Not listed | Rancho Mirage | California | — | — |
| Not listed | Denver | Colorado | — | — |
| Not listed | Norwich | Connecticut | — | — |
| Not listed | Gainsville | Florida | — | — |
| Not listed | Kissimmee | Florida | — | — |
| Not listed | Lecanto | Florida | — | — |
| Not listed | Pensacola | Florida | — | — |
| Not listed | Athens | Georgia | — | — |
| Not listed | Augusta | Georgia | — | — |
| Not listed | Griffin | Georgia | — | — |
| Not listed | Centralia | Illinois | — | — |
| Not listed | Gurnee | Illinois | — | — |
| Not listed | North Chicago | Illinois | — | — |
| Not listed | Olympia Fields | Illinois | — | — |
| Not listed | Park Ridge | Illinois | — | — |
| Not listed | Springfield | Illinois | — | — |
| Not listed | New Albany | Indiana | — | — |
| Not listed | Hutchinson | Kansas | — | — |
| Not listed | Kansas City | Kansas | — | — |
| Not listed | Paducah | Kentucky | — | — |
| Not listed | Baltimore | Maryland | — | — |
| Not listed | Bethesda | Maryland | — | — |
| Not listed | Worcester | Massachusetts | — | — |
| Not listed | Free Soil | Michigan | — | — |
| Not listed | Lansing | Michigan | — | — |
| Not listed | Southfield | Michigan | — | — |
| Not listed | Tupelo | Mississippi | — | — |
| Not listed | Kansas City | Missouri | — | — |
| Not listed | Omaha | Nebraska | — | — |
| Not listed | Englewood | New Jersey | — | — |
| Not listed | Clifton Springs | New York | — | — |
| Not listed | Lake Success | New York | — | — |
| Not listed | Asheville | North Carolina | — | — |
| Not listed | Wilmington | North Carolina | — | — |
| Not listed | Bismarck | North Dakota | — | — |
| Not listed | Canton | Ohio | — | — |
| Not listed | Lancaster | Pennsylvania | — | — |
| Not listed | Philadelphia | Pennsylvania | — | — |
| Not listed | Pottsville | Pennsylvania | — | — |
| Not listed | Aiken | South Carolina | — | — |
| Not listed | Charleston | South Carolina | — | — |
| Not listed | Mt. Pleasant | South Carolina | — | — |
| Not listed | North Charleston | South Carolina | — | — |
| Not listed | Sumter | South Carolina | — | — |
| Not listed | Johnson City | Tennessee | — | — |
| Not listed | Memphis | Tennessee | — | — |
| Not listed | Bryan | Texas | — | — |
| Not listed | El Paso | Texas | — | — |
| Not listed | Galveston | Texas | — | — |
| Not listed | Grapevine | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Tyler | Texas | — | — |
| Not listed | Chesapeake | Virginia | — | — |
| Not listed | Newport News | Virginia | — | — |
| Not listed | Woodbridge | Virginia | — | — |
| Not listed | Vancouver | Washington | — | — |
| Not listed | Walla Walla | Washington | — | — |
| Not listed | Morgantown | West Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00386152, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 18, 2013 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00386152 live on ClinicalTrials.gov.